Asia Pacific Equity Research 06 December 2025 This material is neither intended to be distributed to Mainland China investors nor to provide securities investment consultancy services within the territory of Mainland China. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. Solid State Battery Pilot line sample testing in progress; Expert call takeaways Following a leading battery equipment maker's bullish comments on solid- state batt ...

Financial Data and Key Metrics Changes - In Q2 2025, the company generated revenue of $7,500,000, an increase from $6,000,000 in Q1 2025, bringing year-to-date revenue to $13,500,000 [10] - Operating expenses for Q2 were $33,400,000, up by $3,400,000 compared to $30,000,000 in Q1 2025, primarily due to costs associated with factory acceptance testing [10] - Year-to-date operating loss was $49,900,000, with a net loss of $40,500,000 or $0.22 per share [10] - Capital expenditures totaled $5,000,000, mainly for the construction of the continuous electrolyte production pilot line [10] - Total liquidity at the end of Q2 was $279,800,000 [11] Business Line Data and Key Metrics Changes - The revenue recognized in Q2 was driven by the achievement of the factory acceptance testing milestone under the line installation agreement with SK On [10] - The company is progressing on its electrolyte development roadmap, having completed ordering long lead equipment and begun detailed design for a continuous manufacturing pilot line for sulfide electrolyte production [7] Market Data and Key Metrics Changes - The company has engaged in active sampling of its electrolyte with key strategic customers, indicating ongoing demand for multiple generations of its electrolyte [8] Company Strategy and Development Direction - The company aims to drive electrolyte innovation and performance through feedback from cell development and customers, as highlighted by its partnership with BMW [5] - The collaboration with SK On is focused on developing solid-state cells based on the company's technology and operating a solid-state pilot line [6] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the potential to deliver strong returns for shareholders and acknowledged the commitment and support from employees, partners, and stakeholders [13] Other Important Information - The company repurchased 3,300,000 shares during Q2 at an average price of $1.05, totaling approximately $3,600,000 under its stock repurchase program [11] Q&A Session Summary - The Q&A session was briefly mentioned, but no specific questions or answers were provided in the transcript [14][15]

Financial Data and Key Metrics Changes - In Q1 2025, the company generated revenue of $6 million, a slight increase from $5.9 million in Q1 2024, primarily driven by the SK On agreement and milestone execution [9] - Operating expenses decreased to $30 million, down by $1.7 million compared to Q1 2024, attributed to lower direct labor costs [9] - The operating loss was $24 million, with a net loss of $15 million or 8 cents per share [10] - Total liquidity at the end of the quarter was $300 million, with contract receivables of $2.2 million and total current liabilities of $10.4 million [10][11] Business Line Data and Key Metrics Changes - The company is focused on electrolyte development, with plans to install a continuous manufacturing pilot line at SP2, expected to expand production capacity to 75 metric tons per year [4] - The company is close to completing factory acceptance testing for the SK On line, a key milestone in their line installation agreement [6] - There is ongoing innovation in the Electrolyte Innovation Center, which is being used to develop and test production processes [7] Market Data and Key Metrics Changes - Customer engagement and electrolyte sampling activities have shown positive trends, indicating demand for multiple generations of the electrolyte from both existing and potential new customers [8] Company Strategy and Development Direction - The company aims to balance financial discipline with appropriate investments in technology development and process improvement [11] - The strategic focus includes executing agreements with Eskayon for solid state cell development and ramping up electrolyte sampling to identify long-term customers [5][7] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the transition from traditional lithium-ion to solid-state battery technology, highlighting the importance of customer feedback in driving electrolyte performance improvements [6][8] - The company anticipates significant electrolyte revenue growth starting as early as 2027, with the bulk of revenues expected around 2029 and beyond [20] Other Important Information - The company received $1.5 million in reimbursements under an agreement with the U.S. Department of Energy during the quarter [5][22] Q&A Session Summary Question: How to think about 2025 revenue and timing around revenue from customers for electrolytes? - Management indicated that 2025 revenue is primarily driven by collaborative arrangements, particularly with SK On, and government contracts, with electrolyte sampling at a lower level [15][16] Question: What is the trajectory of revenues potentially beyond 2025? - Management noted that customers are in early stages of cell development, with increased sampling but not large quantities yet, and significant revenue is expected around 2027 to 2030 [19][20] Question: Update on the DOE grant? - Management clarified that the $1.5 million received is a grant, not a loan, and that is the current status [22]